Table 2.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Factor | OR (95 % CI) | p value | OR (95 % CI) | p value |
Age | 1.01 (0.95–1.07) | 0.677 | ||
Sex | 1.50 (0.31–10.87) | 0.629 | ||
BMI | 1.09 (0.89–1.35) | 0.396 | ||
Diabetes mellitus | 3.05 (1.07–9.34) | 0.037 | 3.33 (1.15–10.48) | 0.027 |
Fasting glucose level | 1.01 (0.98–1.05) | 0.363 | ||
2 h OGTT glucose level | 1.02 (1.00–1.03) | 0.032 | 1.02 (1.00–1.04) | 0.098 |
HOMA-IR | 1.10 (0.79–1.51) | 0.570 | ||
eGFR | 1.00 (0.98–1.04) | 0.675 | ||
CPK (maximum) | 1.00 (1.00–1.00) | 0.354 | ||
LDL cholesterol | 0.99 (0.97–1.01) | 0.424 | ||
hs-CRP | 1.05 (0.48–2.13) | 0.904 | ||
NT-proBNP | 1.00 (1.00–1.00) | 0.147 | ||
Ca channel blocker | 0.18 (0.01–1.11) | 0.122 | ||
Beta blocker | 3.35 (0.84–17.03) | 0.105 | ||
ACE-I/ARB | 0.38 (0.02–3.38) | 0.428 | ||
Nitrate | 0.20 (0.05–0.83) | 0.028 | 0.36 (0.07–1.89) | 0.216 |
Statin | 0.39 (0.09–1.60) | 0.180 |
Multivariate logistic regression analysis showed the presence of diabetes mellitus was a significant predictor of no change in the d-ROMs level by 2 weeks after AMI. d-ROMs derivatives of reactive oxygen metabolites, AMI acute myocardial infarction, OR odds ratio, CI confidence interval, BMI body mass index, OGTT oral glucose tolerance test, HOMA-IR homeostatic model assessment-insulin resistance, eGFR estimated glomerular filtration rate, CPK creatine phosphokinase, LDL low density lipoprotein, hs-CRP high-sensitivity C-reactive protein, NT-proBNP N-terminal prohormone of brain natriuretic peptide, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker